Contemporary Neoadjuvant Therapies for High-Risk Melanoma: A Systematic Review.

Boulva, Kerianne; Apte, Sameer; Yu, Ashley; Tran, Alexandre; Shorr, Risa; Song, Xinni; Ong, Michael; Nessim, Carolyn

Boulva, Kerianne; Apte, Sameer; Yu, Ashley; Tran, Alexandre; Shorr, Risa; Song, Xinni; Ong, Michael; Nessim, Carolyn.

Afiliación

Boulva K; Division of General Surgery, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Apte S; Division of General Surgery, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Yu A; The Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.
Tran A; Department of Family Medicine, McMaster University, Hamilton, ON L8P 1H6, Canada.
Shorr R; Division of General Surgery, The Ottawa Hospital, Ottawa, ON K1H 8L6, Canada.
Song X; The Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.
Ong M; The Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.
Nessim C; The Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, Canada.

Cancers (Basel) ; 13(8)2021 Apr 15.

Article en En | MEDLINE | ID: mdl-33920967

Palabras clave

immunotherapy; intralesional therapy; melanoma; neoadjuvant; targeted therapy

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Cancers (Basel) Año: 2021 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google